Cabrellis Pharmaceuticals Corporation
Acquired- Headquarters
- San Diego, California
- Business Model
- B2B
- Acquisition Date
- Nov 2006
Indexed holds 1 funding round for this company. The full record is or through the API.
About
Cabrellis Pharmaceuticals Corporation was a clinical-stage private oncology company dedicated to the development of amrubicin, a third-generation synthetic anthracycline that was in advanced Phase II development for small cell lung cancer (SCLC) in North America and the European Union. Pharmion Corporation acquired Cabrellis Pharmaceuticals in November 2006, gaining US and European rights to amrubicin as part of the transaction.
Summary
Cabrellis Pharmaceuticals Corporation is a Biotech company based in San Diego, United States.
Exit History
Nov 2006
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cabrellis-pharmaceuticals-corporation"><img src="https://indexed.vc/api/badge/company/cabrellis-pharmaceuticals-corporation" alt="Cabrellis Pharmaceuticals Corporation on Indexed.vc" width="260" height="76" /></a>